Medical technology company Medtronic has agreed to acquire insulin pen manufacturer Companion Medical for an undisclosed sum.
Companion Medical’s InPen is an insulin pen system cleared by the US Food and Drug Administration (FDA). It consists of a Bluetooth pen and mobile app that helps users administer the right dose insulin.
The latest acquisition is part of Medtronic’s strategy to advance the automation of insights and dosing capabilities for insulin delivery.
As part of the acquisition, Medtronic plans to expand the global availability of InPen.
